Dr. Dinesh Gaddam, MD

Dr. Gaddam practices at Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System.

Dr. Gaddam's NPI, 1225383391, was assigned on July 16, 2012. Dr. Gaddam holds Oklahoma license 31021.

Dr. Gaddam's primary practice is Saint Francis Hospital, at 6161 South Yale, Tulsa, OK 74136 in Tulsa County. The practice phone is (918) 494-8467.

Dr. Gaddam's primary practice is Saint Francis Hospital in Tulsa, Oklahoma, part of Saint Francis Health System. Dr. Gaddam is also affiliated with Saint Francis Hospital South. The medical group on file is Warren Clinic. Dmand AI also links Dr. Gaddam to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaddam practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gaddam's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gaddam is licensed in Oklahoma.

CMS data shows 1,770 Medicare services from Dr. Gaddam across 8 procedure codes in 2024, for 298 Medicare patients. Medicare paid $152,450 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 298 Medicare patients who saw Dr. Gaddam in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gaddam's median patient age at 72, with 47% women.

In 2024, Dr. Gaddam wrote 564 Medicare Part D claims for 205 patients. 85% of them were for generic drugs. CMS names the drug for 286 of them, across 13 drugs with 11 or more claims each, at $3,960 in total drug cost. In 2023, CMS named 204 claims across 11 drugs.

Dr. Gaddam accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 55 general payments to Dr. Gaddam from 17 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $370.